Atlas Trials

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Clinical trial NCT02679456 · COMPLETED

Trial details

NCT number
NCT02679456
Sponsor
Scynexis, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vulvovaginal Candidiasis
Start date
2015-11-01
Primary completion
2016-08-05
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.